Related Experiment Videos
Special considerations in treating children with epilepsy
1Department of Neurology, Albert Einstein College of Medicine, Einstein/Montefiore Epilepsy Management Center, Bronx, New York 10461, USA.
Insights
Infantile seizures are common due to immature brain susceptibility. Developing age-specific antiepileptic drugs (AEDs) requires considering unique pediatric factors and using developmental models.
Area of Science:
- Pediatric Neurology
- Developmental Neuroscience
- Pharmacology
Background:
- High incidence of seizures in infants and children.
- Epileptic syndromes frequently begin in early life.
- Immature brain exhibits increased seizure susceptibility.
Purpose of the Study:
- To identify factors contributing to increased seizure susceptibility in the immature brain.
- To emphasize the need for age-specific antiepileptic drug (AED) development.
- To propose a strategy for identifying safe and effective pediatric AEDs.
Main Methods:
- Analysis of factors influencing immature brain excitability.
- Consideration of age-specific physiological differences.
- Utilizing developmental epilepsy models for research.
Main Results:
- Identified key factors: excitatory/inhibitory imbalance, age-specific ion transport, epileptogenic stimuli, and perinatal brain anomalies.
- Highlighted the necessity of tailoring AEDs to pediatric physiology.
- Proposed developmental models and clinical trials as crucial steps.
Conclusions:
- Pediatric epilepsy requires specialized approaches.
- Age-specific factors are critical for understanding and treating childhood seizures.
- Developmental models and pediatric clinical trials are essential for advancing AED therapies.
Abstract:
The incidence of seizures is high in infants and children. Many epileptic syndromes have their onset early in life. The increase in seizure susceptibility of the immature brain may be due to several factors, including an imbalance between excitatory and inhibitory processes, age-specific differences in ionic transport and clearance systems, high incidence of epileptogenic stimuli early in life, and the age-specific expression of pre- and perinatal brain anomalies. All of these factors must be taken into account when developing safe and effective age-specific antiepileptic drugs (AEDs). The use of developmental epilepsy models, followed by clinical trials in children, may help identify such AEDs.